Allergy Therapeutics
AGY.L
#7060
Rank
NZ$0.70 B
Marketcap
$0.15
Share price
3.20%
Change (1 day)
123.83%
Change (1 year)

EPS for Allergy Therapeutics (AGY.L)

EPS in 2023: -$0.17

According to Allergy Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.17. In 2023 the company made an earnings per share (EPS) of -$0.17 a decrease over its 2022 EPS that were of -$0.04643.

EPS history for Allergy Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023-$0.17269.76%
2022-$0.04643-516.78%
2021$0.01114-54.41%
2020$0.0244495.71%
2019$0.01249-141.62%
2018-$0.03000206.98%
2017-$0.009774-82.28%
2016-$0.05515-9900.7%
2015$0.0005627-88.46%
2014$0.00487437.81%
2013$0.003537-49.58%
2012$0.007015-128.37%
2011-$0.02473-562.56%
2010$0.005346-101.26%
2009-$0.42-52.19%
2008-$0.88-13.07%
2007-$1.02230.64%
2006-$0.31182.5%
2005-$0.11-211.47%
2004$0.09766-59.61%
2003$0.24-219.2%
2002-$0.20